Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Rapid Micro Biosystems (RPID) EBIT (2020 - 2025)

Historic EBIT for Rapid Micro Biosystems (RPID) over the last 6 years, with Q3 2025 value amounting to -$11.4 million.

  • Rapid Micro Biosystems' EBIT rose 554.03% to -$11.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$45.4 million, marking a year-over-year increase of 1246.77%. This contributed to the annual value of -$49.9 million for FY2024, which is 1174.62% up from last year.
  • According to the latest figures from Q3 2025, Rapid Micro Biosystems' EBIT is -$11.4 million, which was up 554.03% from -$12.1 million recorded in Q2 2025.
  • Rapid Micro Biosystems' EBIT's 5-year high stood at -$9.7 million during Q1 2021, with a 5-year trough of -$17.3 million in Q4 2022.
  • For the 5-year period, Rapid Micro Biosystems' EBIT averaged around -$13.3 million, with its median value being -$13.4 million (2024).
  • Its EBIT has fluctuated over the past 5 years, first crashed by 8067.2% in 2021, then soared by 2938.59% in 2023.
  • Over the past 5 years, Rapid Micro Biosystems' EBIT (Quarter) stood at -$14.6 million in 2021, then decreased by 18.58% to -$17.3 million in 2022, then rose by 29.39% to -$12.2 million in 2023, then increased by 16.07% to -$10.2 million in 2024, then dropped by 11.17% to -$11.4 million in 2025.
  • Its EBIT was -$11.4 million in Q3 2025, compared to -$12.1 million in Q2 2025 and -$11.7 million in Q1 2025.